According to the Fortune Business Insights, The protein sequencing market was valued at USD 1.34 billion in 2025 and is estimated to reach USD 1.47 billion in 2026. It is projected to reach USD 3.15 billion by 2034, exhibiting a CAGR of 10.0% during the forecast period.
The growing prevalence of chronic diseases, expanding pharmaceutical and biotechnology industries, and rising government funding for proteomics research continue to support the expansion of the protein sequencing market. Furthermore, increasing collaborations between academic institutions, research organizations, and biotechnology companies are accelerating innovation and driving the commercialization of advanced protein sequencing technologies. As demand for biomarker discovery and targeted therapeutics continues to grow, the protein sequencing market is expected to remain a key segment within the global life sciences industry.
Continue reading for more details:
https://www.fortunebusinessinsights.com/protein-sequencing-marke-114978
The protein sequencing market is segmented by product, application, end user, and region. Based on product, the market includes instruments, consumables and reagents, and software. Consumables and reagents account for the largest market share owing to their recurring usage in protein sequencing workflows across research laboratories and pharmaceutical companies. By application, the protein sequencing market is categorized into drug discovery and development, clinical diagnostics, genetic engineering, academic research, and others. Drug discovery and development dominate the application segment as pharmaceutical companies increasingly utilize protein sequencing technologies to identify therapeutic targets and improve biologic drug development. Based on end user, the protein sequencing market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and hospitals and diagnostic laboratories. Pharmaceutical and biotechnology companies represent the largest end-user segment due to growing investments in biologics, biosimilars, and precision medicine research. The increasing adoption of advanced analytical platforms across diverse research applications continues to strengthen the long-term growth potential of the protein sequencing market.
The protein sequencing market is expected to experience significant growth throughout the forecast period due to increasing research activities focused on understanding complex biological processes and disease mechanisms. The rapid expansion of precision medicine initiatives worldwide has created substantial demand for advanced protein sequencing technologies capable of identifying disease-specific biomarkers and therapeutic targets. Pharmaceutical and biotechnology companies continue to increase investments in biologic drug development, monoclonal antibodies, vaccines, and cell and gene therapies, further supporting the growth of the protein sequencing market. Technological advancements in mass spectrometry, Edman degradation techniques, artificial intelligence-assisted data analysis, and high-throughput sequencing platforms have significantly improved sequencing accuracy, speed, and efficiency. Growing government funding for life sciences research and rising collaborations between research institutions and industry participants continue to accelerate innovation. The expanding use of protein sequencing in cancer research, infectious disease studies, immunology, neuroscience, and rare disease investigations further contributes to market expansion. Additionally, increasing demand for contract research services and laboratory automation is enabling organizations to conduct large-scale proteomics studies more efficiently. These developments are expected to create numerous growth opportunities for the protein sequencing market throughout the coming years.